| Literature DB >> 30906138 |
Mallela Vijaya Jyothi1, Eranti Bhargav1, Chilamakuru Naresh Babu1, Kanala Somasekhar Reddy1, Bhupalam Pradeep Kumar1, Ravi Prasad Rao2.
Abstract
INTRODUCTION: Caralluma adscendens var. attenuata (Wight) Grav. and Mayur., a member of Apocynaceae, is a perennial stem succulent plant with wide distribution in tropics and subtropics of the world. This plant is reported for the presence of steroids, flavonoids, saponins, triterpenes, and pregnane glycosides, and is known to have antidiabetic and antiulcerogenic properties.Entities:
Keywords: Antioxidant activity; Caralluma adscendens var. attenuata; MTT assay; apoptosis; flavonoids
Year: 2019 PMID: 30906138 PMCID: PMC6394154 DOI: 10.4103/jpbs.JPBS_117_18
Source DB: PubMed Journal: J Pharm Bioallied Sci ISSN: 0975-7406
Figure 1MTT assay for (A) HT29 and (B) HepG2
Determination of total phenolic content and flavonoid content
| Extract | Total phenolic content (mg GAE/g)* | Total flavonoid content (mg RUE/g)* |
|---|---|---|
| n-hexane | 15.3 ± 0.07 | 5.4 ± 0.04 |
| Methanolic | 22.5 ± 0.09 | 6.2 ± 0.05 |
*Mean values (n = 3) with significant difference at P < 0.05.
IC50 values for n-hexane and aqueous methanolic extracts
| Type of cell line | Concentration (μg) | Compound | O.D. at 492 nm | % of cell lysis | IC50 | |||
|---|---|---|---|---|---|---|---|---|
| n-hexane extract | Aqueous methanolic extract | n-hexane extract* | Aqueous methanolic extract* | n-hexane extract* | Aqueous methanolic extract* | |||
| HT29 | 10 | 1 | 2 | 1.819 ± 0.104 | 1.817 ± 0.201 | 50% ± 0.212 | 50% ± 0.102 | 10 μg |
| 20 | 1 | 2 | 2.931 ± 0.126 | 2.934 ± 0.114 | 75% ± 0.211 | 100% ± 0.230 | ||
| 30 | 1 | 2 | 3.045 ± 0.251 | 3.047 ± 0.212 | 100 ± 0.131 | 100% ±0.130 | ||
| - | Control | Control | 0.479 ± 0.175 | 0.476 ± 0.220 | No lysis | No lysis | ||
| HEPG2 | 10 | 1 | 2 | 1.676 ± 0.158 | 1.675 ± 0.120 | 50% ± 0.200 | 50% ± 0.220 | 10 μg |
| 20 | 1 | 2 | 2.092 ± 0.114 | 2.090 ± 0.200 | 75% ± 0.115 | 100% ± 0.125 | ||
| 30 | 1 | 2 | 3.035 ± 0.222 | 3.034 ± 0.115 | 100% ± 0.212 | 100% ± 0.247 | ||
| - | Control | Control | 1.280 ± 0.205 | 1.275 ± 0.210 | No lysis | No lysis | ||
*Data are expressed as mean ± SD, n = 3. OD = optical density
Figure 2Nuclear staining for (A) untreated cancer cell lines, (B) cisplatin-treated (2 g/mL) cell lines, (C) HT29 cell lines treated with methanolic extract, (D) HT29 cell lines treated with n-hexane, (E) HepG2 cell lines treated with methanolic extract, and (F) HepG2 cells treated with n-hexane